COVID–19 NEWS   One COVID-19 Positive case detected on first day of M'sia-S'pore VTL - Khairy | Foreigners with travel history to seven countries not allowed to enter Sarawak | PM to make official visit to S'pore tomorrow in conjunction with VTL launch | COVID: New cases drop to 5,097 Saturday (Nov 27) | Decreasing figures of new COVID cases in Sarawak are genuine, says Uggah | 
COVID-19

Pfizer says its vaccine booster restores full protection against COVID-19

22/10/2021 10:54 AM

WASHINGTON, Oct 22  -- Pfizer and BioNTech announced Thursday that a large-scale trial of their COVID-19 vaccine booster showed it restored full protection against the disease, said Xinhua.

In a Phase 3 randomised, controlled trial, a Pfizer-BioNTech booster dose was administered to more than 10,000 individuals 16 years of age and older, who previously received the Pfizer-BioNTech primary two-dose series.

It showed a relative vaccine efficacy of 95.6 per cent when compared to those who did not receive a booster.

These are the first efficacy results from any randomised, controlled COVID-19 vaccine booster trial.

"These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease," said Albert Bourla, Pfizer chairman and chief executive officer.

Last month, the US Food and Drug Administration authorised the booster shots for the Pfizer-BioNTech COVID-19 vaccine, allowing a single booster dose of the Pfizer-BioNTech vaccine be administered at least 6 months after completion of the primary series to individuals 65 years of age and older, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.

-- BERNAMA

 

 

© 2021 BERNAMA   • Disclaimer   • Privacy Policy   • Security Policy